Sixth Street Partners Management Company »

Context Therapeutics shares owned by Sixth Street Partners Management Company

Quarter-by-quarter ownership of Context Therapeutics (CNTX) shares owned by Sixth Street Partners Management Company from 13F filings

Historical chart of Sixth Street Partners Management Company investment in Context Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Context Therapeutics held by Sixth Street Partners Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Context Therapeutics by Sixth Street Partners Management Company

Quarter filed Position value Share count Share price at filing
2026-06-30 $126k 228k 0.55

More positions owned by Sixth Street Partners Management Company

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Schwab Strategic Tr Fundamental Us L (FNDX)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
UnitedHealth (UNH)
Tesla Motors (TSLA)
Micron Technology (MU)
Schwab Strategic Tr Fundamental Intl (FNDF)
Eli Lilly & Co. (LLY)
Home Depot (HD)

View all positions for Sixth Street Partners Management Company

Top funds holding Context Therapeutics

Nextech Invest
Deep Track Capital
Soleus Capital Management
BlackRock
Avidity Partners Management
Franklin Resources
Vanguard Capital Management
Octagon Capital Advisors
Blue Owl Capital Holdings
TCG Crossover Management
Geode Capital Management
MPM Oncology Impact Management
Renaissance Technologies
Acadian Asset Management
ADAR1 Capital Management

View all funds holding Context Therapeutics